BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17845054)

  • 1. Specific interaction between chitosan and matrix metalloprotease 2 decreases the invasive activity of human melanoma cells.
    Gorzelanny C; Pöppelmann B; Strozyk E; Moerschbacher BM; Schneider SW
    Biomacromolecules; 2007 Oct; 8(10):3035-40. PubMed ID: 17845054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
    Moretti RM; Montagnani Marelli M; Mai S; Limonta P
    Int J Oncol; 2008 Aug; 33(2):405-13. PubMed ID: 18636163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-N-acetyl GM3 promotes melanoma cell migration and invasion through urokinase plasminogen activator receptor signaling-dependent MMP-2 activation.
    Liu JW; Sun P; Yan Q; Paller AS; Gerami P; Ho N; Vashi N; Le Poole IC; Wang XQ
    Cancer Res; 2009 Nov; 69(22):8662-9. PubMed ID: 19903858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.
    Voelcker V; Gebhardt C; Averbeck M; Saalbach A; Wolf V; Weih F; Sleeman J; Anderegg U; Simon J
    Exp Dermatol; 2008 Feb; 17(2):100-7. PubMed ID: 18031543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ING4 in human melanoma cell migration, invasion and patient survival.
    Li J; Martinka M; Li G
    Carcinogenesis; 2008 Jul; 29(7):1373-9. PubMed ID: 18375955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High numbers of human skin cancers express MMP2 and several integrin genes.
    Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
    J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
    Li M; Xie J; Cheng L; Chang B; Wang Y; Lan X; Zhang D; Yin Y; Cheng N
    Cancer Invest; 2008 Nov; 26(9):905-12. PubMed ID: 19034772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
    Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
    Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E1AF, an ets-oncogene transcription factor, highly correlates with malignant phenotype of malignant melanoma through up-regulation of the membrane-type-1 matrix metalloproteinase gene.
    Hata H; Kitamura T; Higashino F; Hida K; Yoshida K; Ohiro Y; Totsuka Y; Kitagawa Y; Shindoh M
    Oncol Rep; 2008 May; 19(5):1093-8. PubMed ID: 18425363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha.
    Tsai CS; Luo SF; Ning CC; Lin CL; Jiang MC; Liao CF
    Biomed Pharmacother; 2009 Aug; 63(7):522-7. PubMed ID: 18849138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a matrix-associated transepithelial resistance invasion assay to precisely measure the invasive potential of synovial fibroblasts.
    Wunrau C; Schnaeker EM; Freyth K; Pundt N; Wendholt D; Neugebauer K; Hansen U; Pap T; Dankbar B
    Arthritis Rheum; 2009 Sep; 60(9):2606-11. PubMed ID: 19714628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo.
    Holle L; Song W; Holle E; Wei Y; Wagner T; Yu X
    Int J Oncol; 2003 Jan; 22(1):93-8. PubMed ID: 12469190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp90 invades the outside.
    Picard D
    Nat Cell Biol; 2004 Jun; 6(6):479-80. PubMed ID: 15170457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts.
    Hatanaka M; Higashi Y; Fukushige T; Baba N; Kawai K; Hashiguchi T; Su J; Zeng W; Chen X; Kanekura T
    Anticancer Res; 2014 Dec; 34(12):7091-6. PubMed ID: 25503136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB.
    Chiang HS; Wu WB; Fang JY; Chen DF; Chen BH; Huang CC; Chen YT; Hung CF
    Life Sci; 2007 Nov; 81(21-22):1509-17. PubMed ID: 17950366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
    Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
    Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale imaging and quantification of local proteolytic activity.
    Kusick S; Bertram H; Oberleithner H; Ludwig T
    J Cell Physiol; 2005 Sep; 204(3):767-74. PubMed ID: 15744770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
    Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
    Hum Pathol; 2008 May; 39(5):731-9. PubMed ID: 18329693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.